HKG Epitherapeutics Ltd receives CLIA certification, a testament to its dedication to excellence in clinical laboratory testing. Discover the impact
Discover the groundbreaking high-throughput test developed by HKG Epitherapeutics and partners for the early detection of Hepatocellular Carcinoma. Utilizing distinctive
Hong Kong, January 12, 2022 The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to
HKG Epitherapeutics is pleased to announce that it has achieved compliance with the federally mandated standards of the Health Insurance
McGill researchers identify new markers for early detection of cervical cancer. While the mortality rate for cervical cancer has declined
HKG Epitherapeutics is on a mission to improve healthcare and well-being for people worldwide Hong Kong (Sept. 30, 2019) –
EpiMedTechGlobal (EMTG)
60 Paya Lebar Road,
#08-06 Paya Lebar Square
Singapore 409051
Honk Kong Lab
Unit 313-315, 3/F Biotech Centre 2
11 Science Park West Avenue
Hong Kong Science Park
US Epitherapeutics
1829 Reisterstown Rd, Suite: 350
Baltimore, MD 21208
+1 (347) 216 0654
MTL Epitherapeutics
600 – 2000 AV McGill College Montreal, QC CA H3A3H3
+1 (514) 448 2185
Shenzhen Lab
Zone E, Floor 4, Building E, Gangzhilong Business Center,
Qinglong Road, Longhua District, Shenzhen
Hong Kong: +(852) 60725262 USA: +1 (347) 216 0654 Canada: +1 (514) 448 2185
Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTechGlobal (EMTG) stands as a force driving innovation. Officially headquartered in Singapore, our organization directs a state-of-the-art research and diagnostic lab located in Hong Kong, which serves as the epicenter of our groundbreaking endeavors. Here, our dedicated scientists are committed to driving innovation in epigenetics and the early detection of diseases. At EMTG, it’s not just about detecting diseases; it’s about unlocking and offering solutions that promote longevity through the hidden stories in our DNA.
©2023, EpiMedTechGlobal. All Rights Reserved.
